<code id='4025B15019'></code><style id='4025B15019'></style>
      • <acronym id='4025B15019'></acronym>
      <center id='4025B15019'><center id='4025B15019'><tfoot id='4025B15019'></tfoot></center><abbr id='4025B15019'><dir id='4025B15019'><tfoot id='4025B15019'></tfoot><noframes id='4025B15019'>
      • <optgroup id='4025B15019'><strike id='4025B15019'><sup id='4025B15019'></sup></strike><code id='4025B15019'></code></optgroup>
        5. <b id='4025B15019'><label id='4025B15019'><select id='4025B15019'><dt id='4025B15019'><span id='4025B15019'></span></dt></select></label></b><u id='4025B15019'></u>
          <i id='4025B15019'><strike id='4025B15019'><tt id='4025B15019'><pre id='4025B15019'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / explore / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-09-30 21:23:34 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：focus   
                                        
                                      
                                      Page View：95
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Rune Labs, whose app tracks Parkinson's symptoms, raises $12M
                                
                            
          Next article：  
                                      
                                          How one medical school became remarkably diverse
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles